|
US2472133A
(en)
|
1947-03-20 |
1949-06-07 |
Du Pont |
Thiophanthraquinone derivatives
|
|
SU1049490A1
(ru)
|
1982-05-18 |
1983-10-23 |
Ордена Трудового Красного Знамени Институт Химии Ан Мсср |
(3 @ ,9 @ ,9 @ )-6,6,9 @ -Триметилтранспергидронафто(2,1- @ )фуран,в качестве душистого компонента парфюмерной композиции
|
|
JPS63196576A
(ja)
|
1987-02-10 |
1988-08-15 |
Tetsuo Ikegawa |
フラルナフトキノン誘導体と制癌剤及びその製造方法
|
|
US5846534A
(en)
|
1988-02-12 |
1998-12-08 |
British Technology Group Limited |
Antibodies to the antigen campath-1
|
|
JPH04139177A
(ja)
|
1989-12-28 |
1992-05-13 |
Dainippon Ink & Chem Inc |
フラルベンゾキノン誘導体及びその製造方法並びに制癌剤
|
|
DE69131874T2
(de)
|
1990-07-10 |
2000-06-15 |
Canon K.K., Tokio/Tokyo |
Elektrophotographisches empfindliches Element
|
|
TW252136B
(enExample)
|
1992-10-08 |
1995-07-21 |
Ciba Geigy |
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
ATE139900T1
(de)
|
1992-11-13 |
1996-07-15 |
Idec Pharma Corp |
Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
|
|
US5595721A
(en)
|
1993-09-16 |
1997-01-21 |
Coulter Pharmaceutical, Inc. |
Radioimmunotherapy of lymphoma using anti-CD20
|
|
GB9603507D0
(en)
|
1996-02-20 |
1996-04-17 |
Isis Innovation |
Antibody variants
|
|
JP3598168B2
(ja)
|
1996-03-18 |
2004-12-08 |
独立行政法人 科学技術振興機構 |
抗ウイルス剤
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
JPH1121284A
(ja)
|
1997-06-30 |
1999-01-26 |
Kotobuki:Kk |
フラノナフトキノン誘導体及びこれを含有する医薬
|
|
JPH1165141A
(ja)
|
1997-08-11 |
1999-03-05 |
Canon Inc |
電子写真感光体、該電子写真感光体を有するプロセスカ−トリッジ及び電子写真装置
|
|
US6174913B1
(en)
|
1998-06-05 |
2001-01-16 |
The University Of North Carolina At Chapel Hill |
Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
|
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
|
US7109003B2
(en)
|
1998-12-23 |
2006-09-19 |
Abgenix, Inc. |
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
|
|
EP1897540A3
(en)
|
1999-01-27 |
2008-07-23 |
University Of South Florida |
Inhibition of STAT3 signal transduction for human cancer therapy
|
|
JP2003525862A
(ja)
|
1999-01-27 |
2003-09-02 |
ザ ユニヴァーシティー オブ サウス フロリダ |
ヒト癌の治療のためのｓｔａｔ３シグナル伝達の阻害
|
|
EP1169021B1
(en)
|
1999-04-01 |
2009-09-16 |
Hana Biosciences, Inc. |
Compositions and methods for treating lymphoma
|
|
US6482943B1
(en)
|
1999-04-30 |
2002-11-19 |
Slil Biomedical Corporation |
Quinones as disease therapies
|
|
PT1206436E
(pt)
|
1999-08-02 |
2004-12-31 |
Hoffmann La Roche |
Retinoides para o tratamento de enfisema
|
|
US7605238B2
(en)
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
|
NZ517202A
(en)
|
1999-08-24 |
2004-05-28 |
Medarex Inc |
Human CTLA-4 antibodies and their uses
|
|
JP2001097860A
(ja)
|
1999-09-29 |
2001-04-10 |
Japan Science & Technology Corp |
抗薬剤耐性菌剤と抗クラミジア剤
|
|
UA75055C2
(uk)
|
1999-11-30 |
2006-03-15 |
Пфайзер Продактс Інк. |
Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
|
|
KR20010100194A
(ko)
|
2000-03-13 |
2001-11-14 |
박호군 |
여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법
|
|
JP4334866B2
(ja)
|
2000-10-09 |
2009-09-30 |
アイシス イノヴェイション リミテッド |
治療用抗体
|
|
US7090843B1
(en)
|
2000-11-28 |
2006-08-15 |
Seattle Genetics, Inc. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
US7998947B2
(en)
|
2001-03-28 |
2011-08-16 |
University Of South Florida |
Materials and methods for treatment of cancer and identification of anti-cancer compounds
|
|
GB0117696D0
(en)
|
2001-07-20 |
2001-09-12 |
Bradford Particle Design Plc |
Particle information
|
|
AU2002357012A1
(en)
|
2001-11-27 |
2003-06-10 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
|
JP2005517637A
(ja)
|
2001-11-29 |
2005-06-16 |
セラコス・インコーポレイテッド |
体外フォトフォレーシスおよび／またはアポプトーシス細胞による一定の被験体を前処理するための方法
|
|
DE60307701T2
(de)
|
2002-03-15 |
2007-10-11 |
Natimmune A/S |
Mannose-Bindungsprotein enthaltende pharmazeutische Zusammensetzungen
|
|
JP2005522514A
(ja)
|
2002-04-10 |
2005-07-28 |
ジェネンテック・インコーポレーテッド |
抗ｈｅｒ２抗体改変体
|
|
DE60334303D1
(de)
|
2002-07-03 |
2010-11-04 |
Tasuku Honjo |
Immunpotenzierende zusammensetzungen
|
|
DE60335383D1
(de)
|
2002-07-15 |
2011-01-27 |
Univ Texas |
Antikörper mit bindung an anionische phospholipide und aminophospholipide und ihre verwendung bei der behandlung von virusinfektionen
|
|
WO2004026253A2
(en)
|
2002-09-17 |
2004-04-01 |
Arqule, Inc. |
Novel lapacho compounds and methods of use thereof
|
|
KR100944575B1
(ko)
|
2002-10-17 |
2010-02-25 |
젠맵 에이/에스 |
Ｃｄ20에 대한 인간 모노클로날 항체
|
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
|
TWI323662B
(en)
|
2002-11-15 |
2010-04-21 |
Telik Inc |
Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
|
|
IS6633A
(is)
|
2002-11-22 |
2004-05-23 |
Omega Farma Ehf. |
Samsetningar af fínasteríð töflum
|
|
US20060019256A1
(en)
|
2003-06-09 |
2006-01-26 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
MXPA05014155A
(es)
|
2003-06-27 |
2006-05-25 |
Abgenix Inc |
Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos.
|
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
US20050049207A1
(en)
|
2003-09-03 |
2005-03-03 |
Kaufmann Doug A. |
Method of treating and preventing cancer
|
|
WO2005033048A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Wnt pathway antagonists
|
|
US7288638B2
(en)
|
2003-10-10 |
2007-10-30 |
Bristol-Myers Squibb Company |
Fully human antibodies against human 4-1BB
|
|
EP1694706B1
(en)
|
2003-11-01 |
2012-04-04 |
Merck Patent GmbH |
Modified anti-cd52 antibody
|
|
EP1706133B1
(en)
|
2003-12-02 |
2010-10-06 |
Cleveland Clinic Foundation |
Methods of protecting against radiation using flagellin
|
|
EP2487156B1
(en)
|
2003-12-11 |
2014-07-16 |
Board Of Regents The University Of Texas System |
Compounds for treatment of cell proliferative diseases
|
|
DE10359828A1
(de)
|
2003-12-12 |
2005-07-28 |
Zoser B. Dr.Rer.Nat. Salama |
CHP-Gemcitabin- Kombinationsmittel und ihre Verwendung als Antitumorwirkstoffe, insbesondere Antimetastasierungswirkstoffe
|
|
WO2005110477A2
(en)
|
2004-04-09 |
2005-11-24 |
University Of South Florida |
Combination therapies for cancer and proliferative angiopathies
|
|
JP2004224802A
(ja)
|
2004-04-21 |
2004-08-12 |
Japan Science & Technology Agency |
抗菌剤
|
|
CA2601417C
(en)
|
2004-07-01 |
2018-10-30 |
Novo Nordisk A/S |
Human anti-kir antibodies
|
|
AU2005270102A1
(en)
|
2004-07-02 |
2006-02-09 |
Icos Corporation |
Compounds useful for inhibiting Chk1
|
|
UA90480C2
(uk)
|
2004-07-22 |
2010-05-11 |
Джэнэнтэк, Инк. |
Фармацевтична композиція, що має протипухлинну активність, яка включає антитіло до her2
|
|
KR20070046175A
(ko)
|
2004-08-18 |
2007-05-02 |
아스트라제네카 아베 |
선택된 융합 복소환 및 이의 용도
|
|
CA2587276A1
(en)
|
2004-11-08 |
2006-05-18 |
Baxter International Inc. |
Nanoparticulate compositions of tubulin inhibitor compounds
|
|
RU2007123675A
(ru)
|
2004-11-24 |
2008-12-27 |
Новартис АГ (CH) |
Комбинации ингибиторов jak
|
|
WO2006065894A2
(en)
|
2004-12-14 |
2006-06-22 |
University Of South Florida |
Methods for inhibiting stat3 signaling in immune cells
|
|
US7807662B2
(en)
|
2004-12-23 |
2010-10-05 |
University Of South Florida |
Platinum IV complex inhibitor
|
|
JP2008535785A
(ja)
|
2005-02-25 |
2008-09-04 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Ｓｔａｔ３の小分子阻害剤およびその使用
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
JP2006290871A
(ja)
|
2005-03-16 |
2006-10-26 |
Taheebo Japan Kk |
抗癌性を示す化合物およびその中間体ならびにそれらの製造方法
|
|
US20060252073A1
(en)
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
|
EP3530736A3
(en)
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
|
KR101704734B1
(ko)
|
2005-07-01 |
2017-02-09 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
US20070009532A1
(en)
|
2005-07-06 |
2007-01-11 |
Branimir Sikic |
Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
|
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
|
JP2007145680A
(ja)
|
2005-11-30 |
2007-06-14 |
Idemitsu Kosan Co Ltd |
水素発生材料および水素発生方法
|
|
WO2007074347A1
(en)
|
2005-12-24 |
2007-07-05 |
Biotica Technology Ltd. |
21-deoxymacbecin analogues useful as antitumor agents
|
|
US20090012075A1
(en)
|
2006-01-12 |
2009-01-08 |
Miller Thomas A |
Fluorinated Arylamide Derivatives
|
|
KR101478164B1
(ko)
|
2006-02-09 |
2014-12-31 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
WO2007100640A2
(en)
|
2006-02-21 |
2007-09-07 |
The Regents Of The University Of Michigan |
Growth hormone receptor antagonist cancer treatment
|
|
WO2007095753A1
(en)
|
2006-02-24 |
2007-08-30 |
Merck Frosst Canada Ltd. |
2-(phenyl or heterocyclic) - 1h-phenanthro [9,10-d] imidazoles
|
|
WO2007115269A2
(en)
|
2006-03-31 |
2007-10-11 |
The Board Of Regents Of The University Of Texas System |
Orally bioavailable caffeic acid related anticancer drugs
|
|
US20070238770A1
(en)
|
2006-04-05 |
2007-10-11 |
Bristol-Myers Squibb Company |
Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations
|
|
US8828451B2
(en)
|
2006-10-04 |
2014-09-09 |
University Of South Florida |
Akt sensitization of cancer cells
|
|
WO2008077062A2
(en)
|
2006-12-19 |
2008-06-26 |
Board Of Regents, The University Of Texas System |
Suppression of stat3 reactivation after src kinase inhibition to treat cancer
|
|
JP4077863B1
(ja)
|
2007-05-31 |
2008-04-23 |
タヒボジャパン株式会社 |
抗癌活性を有する光学活性２−（１−ヒドロキシエチル）−５−ヒドロキシナフト［２，３−ｂ］フラン−４，９−ジオンの製法
|
|
PT2170959E
(pt)
|
2007-06-18 |
2014-01-07 |
Merck Sharp & Dohme |
Anticorpos para o receptor humano de morte programada pd-1
|
|
EP3121281B1
(en)
|
2007-08-27 |
2021-03-31 |
1Globe Health Institute LLC |
Compositions of asymmetric interfering rna and uses thereof
|
|
EP2190429B1
(en)
|
2007-09-10 |
2016-04-20 |
Boston Biomedical, Inc. |
A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
WO2009060282A2
(en)
|
2007-11-06 |
2009-05-14 |
Orchid Research Laboratories Limited |
Stilbene derivatives as pstat3/il-6 inhibitors
|
|
US20100297118A1
(en)
|
2007-12-27 |
2010-11-25 |
Macdougall John |
Therapeutic Cancer Treatments
|
|
WO2010014784A2
(en)
|
2008-08-01 |
2010-02-04 |
Bristol-Myers Squibb Company |
Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
|
|
WO2010098788A2
(en)
|
2008-08-25 |
2010-09-02 |
Amplimmune, Inc. |
Pd-i antagonists and methods for treating infectious disease
|
|
MX356367B
(es)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t.
|
|
MX2011012047A
(es)
|
2009-05-13 |
2011-12-14 |
Genzyme Corp |
Inmunoglobulinas humanas anti-cd52.
|
|
US8267122B2
(en)
|
2009-06-30 |
2012-09-18 |
Ge Aviation Systems Llc |
Method and systems for bleed air supply
|
|
EP2504028A4
(en)
|
2009-11-24 |
2014-04-09 |
Amplimmune Inc |
SIMULTANEOUS INHIBITION OF PD-L1 / PD-L2
|
|
EP3279215B1
(en)
|
2009-11-24 |
2020-02-12 |
MedImmune Limited |
Targeted binding agents against b7-h1
|
|
WO2011084694A1
(en)
|
2009-12-17 |
2011-07-14 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Stabilized stat3 decoy oligonucleotides and uses therefor
|
|
DK2542256T3
(da)
|
2010-03-04 |
2019-08-26 |
Macrogenics Inc |
Antistoffer reagerende med b7-h3, immunologisk aktive fragmenter deraf og anvendelser deraf
|
|
PH12012501751A1
(en)
|
2010-03-04 |
2012-11-12 |
Macrogenics Inc |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
|
DK2547205T3
(da)
|
2010-03-19 |
2024-05-27 |
1Globe Biomedical Co Ltd |
Hidtil ukendte fremgangsmåder til målretning mod cancerstamceller
|
|
NZ602328A
(en)
|
2010-03-19 |
2014-11-28 |
Boston Biomedical Inc |
Novel compounds and compositions for targeting cancer stem cells
|
|
CN104016951B
(zh)
|
2010-03-19 |
2016-07-13 |
北京强新生物科技有限公司 |
靶向癌症干细胞的化合物和组合物
|
|
AU2015218436B9
(en)
|
2010-03-19 |
2017-03-09 |
Boston Biomedical, Inc. |
Novel Methods For Targeting Cancer Stem Cells
|
|
JP5208239B2
(ja)
|
2010-09-29 |
2013-06-12 |
タヒボジャパン株式会社 |
アルキンカップリングによる抗がん活性三環式化合物の新規製法
|
|
CN103402993A
(zh)
|
2011-03-04 |
2013-11-20 |
舟山海中洲新生药业有限公司 |
用于疾病治疗的4，9-二羟基-萘并[2,3-b] 呋喃新型酯
|
|
WO2012135408A1
(en)
|
2011-03-31 |
2012-10-04 |
Merck Sharp & Dohme Corp. |
Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments
|
|
US8977803B2
(en)
|
2011-11-21 |
2015-03-10 |
Western Digital Technologies, Inc. |
Disk drive data caching using a multi-tiered memory
|
|
WO2013166618A1
(en)
|
2012-05-08 |
2013-11-14 |
Zhoushan Haizhongzhou Xinsheng Pharmaceuticals Co., Ltd. |
PRODRUGS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR CIRCUMVENTING CANCER MULTIDRUG RESISTANCE
|
|
WO2013172918A1
(en)
|
2012-05-15 |
2013-11-21 |
University Of Southern California |
Ksr1 gene polymorphism for use in predicting outcome and therapy selection
|
|
US9856320B2
(en)
|
2012-05-15 |
2018-01-02 |
Bristol-Myers Squibb Company |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
|
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
|
US20160030384A1
(en)
|
2013-04-09 |
2016-02-04 |
Boston Biomedical, Inc. |
2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
|
|
JP6199787B2
(ja)
|
2014-03-28 |
2017-09-20 |
京セラドキュメントソリューションズ株式会社 |
画像形成装置
|
|
EP3043778B1
(en)
|
2013-09-13 |
2017-09-06 |
Bayer Pharma Aktiengesellschaft |
Pharmaceutical compositions containing refametinib
|
|
EP3129009A1
(en)
|
2014-04-08 |
2017-02-15 |
Teva Pharmaceutical Industries Ltd |
Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
|
|
EP3153508B1
(en)
|
2014-06-09 |
2020-03-18 |
Kyoto Pharmaceutical Industries, Ltd. |
Naphthofuran derivatives for use as anticancer agents
|
|
JP2016016973A
(ja)
|
2014-07-10 |
2016-02-01 |
株式会社リコー |
シート処理装置
|
|
WO2016030455A1
(en)
|
2014-08-28 |
2016-03-03 |
Medimmune Limited |
Anti-b7-h1 and anti-ctla-4 antibodies for treating non-small lung cancer
|
|
CA2944085C
(en)
|
2014-09-16 |
2018-04-10 |
Ease Charm Limited |
Anti-egfr antibody and uses of same
|
|
US10183925B2
(en)
|
2015-03-27 |
2019-01-22 |
Boston Biomedical, Inc. |
Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer
|
|
JP2018511643A
(ja)
|
2015-04-17 |
2018-04-26 |
ボストン バイオメディカル， インコーポレイテッド |
癌を治療するための方法
|
|
WO2016168857A1
(en)
|
2015-04-17 |
2016-10-20 |
Boston Biomedical, Inc. |
Methods for treating cancer
|
|
KR20170137833A
(ko)
|
2015-04-17 |
2017-12-13 |
보스톤 바이오메디칼, 인크. |
암의 치료 방법
|
|
KR20170141716A
(ko)
|
2015-04-27 |
2017-12-26 |
보스톤 바이오메디칼, 인크. |
Stat3 경로 저해제 및 카이나제 저해제를 사용하여 암을 치료하는 방법
|
|
WO2016196935A1
(en)
|
2015-06-03 |
2016-12-08 |
Boston Biomedical, Inc. |
Compositions comprising a cancer stemness inhibitor and an immunotherapeutic agent for use in treating cancer
|
|
US10329267B2
(en)
|
2015-07-17 |
2019-06-25 |
Sumitomo Dainippon Pharma Co., Ltd. |
Method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione
|
|
WO2017132049A1
(en)
|
2016-01-20 |
2017-08-03 |
Boston Biomedical, Inc. |
Methods for treating cancer
|
|
WO2017164379A1
(ja)
|
2016-03-25 |
2017-09-28 |
大日本住友製薬株式会社 |
２－アルキルカルボニルナフト［２，３－ｂ］フラン－４，９－ジオンの関連物質の製造方法、及びその関連物質
|
|
WO2018096401A1
(en)
|
2016-11-22 |
2018-05-31 |
Hitoshi Ban |
New naphtho[2,3-b]furan derivatives
|
|
JP2020512377A
(ja)
|
2017-03-30 |
2020-04-23 |
ボストン バイオメディカル， インコーポレイテッド |
がんを処置および／または防止するための組成物
|
|
JP2020520923A
(ja)
|
2017-05-17 |
2020-07-16 |
ボストン バイオメディカル， インコーポレイテッド |
がんを処置するための方法
|
|
JP2019110987A
(ja)
|
2017-12-21 |
2019-07-11 |
オムロンヘルスケア株式会社 |
測定装置およびプログラム
|